Osaka Pharmaceuticals Private Limited, a active private limited company, was established on 09 March 2004 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24231GJ2004PTC043750. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹9.00 Cr and a paid-up capital of ₹7.93 Cr.
It upholds a active non-compliant status. Employing 22 professional, Its leadership includes Monika Sachin Bhandari (Director), Sachin Subhashchandra Bhandari (Director). Past directors included Nitin Kantilal Muchhala, Prakash Multanmal Shah, Rajen Dasharathlal Kacheria. It holds ₹81.61 Cr open charges and ₹86.61 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Old N.H. No- 8, Vadodara, Gujarat, 391350.
U24231GJ2004PTC043750
043750
09 March 2004
₹9.00 Cr
₹7.93 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Osaka Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Monika Sachin Bhandari | Director | 17 May 2023 | Current |
| Sachin Subhashchandra Bhandari | Director | 17 May 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Feb 2018 | Past |
| Pramod Abcsdd | Director | 30 Apr 2013 | Past |
| Pramod Abcsdd | Whole-Time Director | 17 May 2023 | Past |
| Pramod Abcsdd | Additional Director | 17 May 2023 | Past |
| Pramod Abcsdd | Nominee Director | 15 Apr 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Osaka Pharmaceuticals Private Limited, for the financial year ended 2015, experienced significant growth in revenue, with a 11.39% increase. The company also saw a substantial fall in profitability, with a 77.84% decrease in profit. The company's net worth moved up by a moderate rise of 4.03%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Osaka Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹816,091,063.00
₹866,091,063.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2014 | Electronica Finance Limited | ₹1.43 M | Satisfied |
| 08 Jun 2013 | Oriental Bank Of Commerce | ₹3.50 Cr | Satisfied |
| 27 Dec 2011 | Oriental Bank Of Commerce | ₹26.68 Cr | Satisfied |
| 09 Jun 2011 | Oriental Bank Of Commerce | ₹4.00 Cr | Satisfied |
| 09 Jun 2011 | Oriental Bank Of Commerce | ₹20.60 Cr | Satisfied |
Explore comprehensive loan charge details -
Osaka Pharmaceuticals has a workforce of 22 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Osaka Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Osaka Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Osaka Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Osaka Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.
A charge registered on 08 Jun 2013 via Charge ID 10435011 with Oriental Bank Of Commerce was fully satisfied on 06 Nov 2024. was recorded as a recent event.
Progress on A charge registered on 27 Dec 2011 via Charge ID 10326379 with Oriental Bank Of Commerce was fully satisfied on 06 Nov 2024. was documented.
Progress on A charge registered on 09 Jun 2011 via Charge ID 10295172 with Oriental Bank Of Commerce was fully satisfied on 06 Nov 2024. was documented.
Progress on A charge registered on 09 Jun 2011 via Charge ID 10295179 with Oriental Bank Of Commerce was fully satisfied on 06 Nov 2024. was documented.
The CIN of Osaka Pharmaceuticals Private Limited is U24231GJ2004PTC043750.
Osaka Pharmaceuticals Private Limited is headquartered at Old N.H. No- 8, Vadodara, Gujarat, 391350.
Osaka Pharmaceuticals Private Limited was incorporated on 09 March 2004.
The current directors of Osaka Pharmaceuticals Private Limited are
The primary industry of Osaka Pharmaceuticals Private Limited is Pharma.
Osaka Pharmaceuticals Private Limited is unlisted.
The authorized capital of Osaka Pharmaceuticals Private Limited is ₹9.00 Cr, and the paid-up capital is ₹7.93 Cr.
The compliance status of Osaka Pharmaceuticals Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX